Fulltext

A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging

Mehnert, Ulrich ; Boy, Sönke ; Schmid, Marius ; Reitz, André ; von Hessling, Alexander ; Hodler, Juerg ; Schurch, Brigitte

In: World Journal of Urology, 2009, vol. 27, no. 3, p. 397-403

Ajouter à la liste personnelle
    Titre
    • A morphological evaluation of botulinum neurotoxin A injections into the detrusor muscle using magnetic resonance imaging
    Auteur
    • Mehnert, Ulrich. Neurourology, Spinal Cord Injury Center, Balgrist University Hospital, Forchstrasse 340, 8008, Zurich, Switzerland
    • Boy, Sönke. Neurourology, Spinal Cord Injury Center, Balgrist University Hospital, Forchstrasse 340, 8008, Zurich, Switzerland
    • Schmid, Marius. Department of Radiology, Balgrist University Hospital, Forchstrasse 340, 8008, Zurich, Switzerland
    • Reitz, André. Neurourology, Spinal Cord Injury Center, Balgrist University Hospital, Forchstrasse 340, 8008, Zurich, Switzerland
    • von Hessling, Alexander. Department of Radiology, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9000, St. Gallen, Switzerland
    • Hodler, Juerg. Department of Radiology, Balgrist University Hospital, Forchstrasse 340, 8008, Zurich, Switzerland
    • Schurch, Brigitte. Neurourology, Spinal Cord Injury Center, Balgrist University Hospital, Forchstrasse 340, 8008, Zurich, Switzerland
    Type de document
    • Postprint
    Identifiant OAI-PMH
    • oai:doc.rero.ch:318374
    Summary
    Objectives: Although botulinum neurotoxin type A (BoNT/A) intradetrusor injections are a recommended therapy for neurogenic detrusor overactivity (NDO), refractory to antimuscarinic drugs, a standardisation of injection technique is missing. Furthermore, some basic questions are still unanswered, as where the toxin solution exactly spreads after injection. Therefore, we investigated the distribution of the toxin solution after injection into the bladder wall, using magnet resonance imaging (MRI). Methods: Six patients with NDO were recruited. Three of six patients received 300U of BoNT/A+contrast agent distributed over 30 injection sites (group 1). The other three patients received 300U of BoNT/A+contrast agent distributed over 10 injection sites (group 2). Immediately after injection, MRI of the pelvis was performed. The volume of the detrusor and the total volume of contrast medium inside and outside the bladder wall were calculated. Results: In all patients, a small volume (mean 17.6%) was found at the lateral aspects of the bladder dome in the extraperitoneal fat tissue, whereas 82.4% of the injected volume reached the target area (detrusor). In both groups there was a similar distribution of the contrast medium in the target area. A mean of 33.3 and 25.3% of the total detrusor volume was covered in group 1 and 2, respectively. Six weeks after injection, five of six patients were continent and showed no detrusor overactivity in the urodynamic follow-up. No systemic side effects were observed. Conclusions: Our results provide morphological arguments that the currently used injection techniques are appropriate and safe